Biguanides

Atovaquone

Approved 28 Apr 2017OralSuspension

The FDA lists this product in 9 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: ATOVAQUONE 750MG/5ML

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA207833.

Open Drugs@FDA

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Atovaquone
Drug class: Biguanides, Other agents against amoebiasis and other protozoal diseases
Group: Diabetes medicines
Route: Oral
Dosage form: Suspension
Applicant: Chartwell RX
Status: Prescription
FDA approval: 28 Apr 2017
Application: ANDA207833-001
RxCUI: 60212